• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DYAX:US

9.1500 USD 0.2700 2.87%

As of 20:10:00 ET on 08/01/2014.

Snapshot for Dyax Corp (DYAX)

Open: 9.3900 Day's Range: 8.9600 - 9.6870 Volume: 929,063
Previous Close: 9.4200 52wk Range: 3.8600 - 10.9900 1-Yr Rtn: +128.18%

Stock Chart for DYAX

No chart data available.
  • DYAX:US 9.1500
  • 1D
  • 1M
  • 1Y
9.4200
Interactive DYAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DYAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1500
Est. EPS (USD) (12/2014) -0.1960
Est. PEG Ratio -
Market Cap (M USD) 1,246.28
Shares Outstanding (M) 136.21
30 Day Average Volume 1,165,008
Price/Book (mrq) 12.0693
Price/Sale (ttm) 17.4891
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DYAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DYAX

Dyax Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology. The Company currently has two recombinant proteins, DX-88 and DX-890 in phase II clinical trials.

Gustav A ChristensenPresident/CEOGeorge V MigauskyExec VP/CFO
Burt A AdelmanExec VP/Chief Medical OfcrAndrew AsheExec VP/General Counsel
More Company Profile & Key Executives for DYAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil